课题基金 / 基金详情

ROS Mechanisms in BAV Aortopathy

ROS Mechanisms in BAV Aortopathy
BAV 主动脉病中的 ROS 机制
批准号:
10675526
负责人:
Thomas Gillette Gleason
金额:
$71.82万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2025-06-30

项目摘要

项目成果

Thomas Gillette Gleason的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Ascending aortic aneurysmal disease is a major worldwide health problem. Bicuspid aortic valve (BAV)- associated aortopathy represents the largest subset of affected patients and this congenital anomaly is present in 1-2% of the general population. Current aortic diameter-based guidelines for surgical intervention stem from a non-controlled extrapolation of natural history data that does not reflect patient-specific aortic catastrophe risk rendering under-treatment in some patients and over-treatment in others. This is largely because there is an incomplete understanding of what biological and biomechanical features are unique to BAV-associated aortopathy or other degenerative aneurysms and how these insults potentiate aortic dissection. During the prior funding period, we uncovered several cellular, tissue architectural, and biomechanical-based features distinguishing BAV-associated aortopathy from that of degenerative aneurysms. We discovered that elevated production of superoxide anion by medial smooth muscle cells, increased oxidative stress-induced cellular damages, and a biomechanical strength profile coupled with an anisotrophic collagen and elastin microarchitecture uniquely define the tissue microenvironment of the BAV aorta. In the next phase of the project, we will elucidate how an interplay of mechanical and oxidative stress mediates ECM remodeling, determine where hypoxia comes into play, and how clinical imaging-derived metrics correspond to cellular and tissue aberrations in the BAV aorta. In a two-aim approach, we will test the central hypothesis that mechanical forces- and local hypoxia-induced oxidative stress invokes differential ECM remodeling in BAV and TAV patients, and these insults can be correlated to patient-specific aortic wall indices that can be imaged, bundled and used to predict disease progression and/or aortic catastrophe. Aim 1's approach will employ our established patient-specific 3D culture models to determine how mechanical stretch and low oxygen tension impact antioxidant response, free radical production, cellular oxidative damages, and influence ECM production, microarchitecture and degradation in BAV aorta-derived smooth muscle cells. In Aim 2, quantification of local hypoxic effects, measures of oxidative cellular damages, ECM microarchitecture, and biochemical ECM composition will be regionally compared and then correlated with patient-specific wall shear stress measurements from 4D flow MRI, aortic wall morphometrics from dynamic ECG-gated CTA, and distensibility metrics from echocardiography to develop a workable patient-specific multi-parameter imaging- based paradigm. Completion of this project phase will generate an aortic bio-map that profiles mechanical and oxidative stress-mediated ECM remodeling in BAV-associated aortopathy and will identify what in vivo bio- imaging endpoints correlate with these tissue insults. A perceived deliverable is a set of building blocks for a workable multi-parameter computational model whose main output will be a patient specific aortic integrity score that more accurately identifies dissection risk for a given patient. This work will also reveal new opportunities for the implementation of PET-based probes to non-invasively detect local aortic vulnerability and identify novel targets for medical therapeutic intervention.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jtcvs.2016.02.019
发表时间: 2016-06
期刊: The Journal of thoracic and cardiovascular surgery
影响因子: --
作者: [Tsamis A, Phillippi JA, Koch RG, Chan PG, Krawiec JT, D'Amore A, Watkins SC, Wagner WR, Vorp DA, Gleason TG]
通讯作者: Gleason TG
Layer-specific Nos3 expression and genotypic distribution in bicuspid aortic valve aortopathy.
二叶式主动脉瓣主动脉病中层特异性 Nos3 表达和基因型分布。
DOI: 10.1093/ejcts/ezac237
发表时间: 2022
期刊: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
影响因子: --
作者: [Hill,JenniferC, Billaud,Marie, Richards,TaraD, Kotlarczyk,MaryP, Shiva,Sruti, Phillippi,JulieA, Gleason,ThomasG]
通讯作者: Gleason,ThomasG
DOI: 10.1016/j.jtcvs.2013.04.028
发表时间: 2014-03
期刊: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
影响因子: 6
作者: [Phillippi, Julie A., Green, Benjamin R., Eskay, Michael A., Kotlarczyk, Mary P., Hill, Michael R., Robertson, Anne M., Watkins, Simon C., Vorp, David A., Gleason, Thomas G.]
通讯作者: Gleason, Thomas G.
DOI: 10.1053/j.optechstcvs.2019.06.002
发表时间: 2019-01-01
期刊: Operative techniques in thoracic and cardiovascular surgery : a comparative atlas : an official publication of the American Association for Thoracic Surgery
影响因子: --
作者: [Dufendach, Keith A, Sultan, Ibrahim, Gleason, Thomas G]
通讯作者: Gleason, Thomas G
11
    ROS mechanisms in BAV aortopathy
    • 批准号:
      10439298
    • 项目类别:
    • 资助金额:
      $69.68万
    • 财政年份:
      2021
    • 负责人:
      Thomas Gillette Gleason
    • 依托单位:
    ROS Mechanisms in BAV Aortopathy
    ROS Mechanisms in BAV Aortopathy
    ROS Mechanisms in BAV Aortopathy
    海外基金